Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Japanese researchers disclose anticancer applications of the E1AF gene

Oct. 25, 1996

New antitumor agent from Banyu

Oct. 25, 1996

CRC Technology reports antitumor activity of DF-203

Oct. 25, 1996

Hybridon anti-VEGF antisense compounds for neovascularization disorders

Oct. 25, 1996

MAb 1DT3-D disclosed for treatment of B-cell lymphoma

Oct. 25, 1996

INSERM claims antitumor antibody

Oct. 25, 1996

Tokyo Tanabe discloses agents for the treatment of diarrhea

Oct. 18, 1996

Gastric antisecretory agents disclosed by Il-Yang

Oct. 18, 1996

Merck persists in the search for BPH therapeutics

Oct. 18, 1996

Antiplatelet agents from Taisho

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...